NOI to Sole Source to QuVa Pharma, Inc.
NOI-OD-26-000038 · HEALTH AND HUMAN SERVICES, DEPARTMENT OF
A PHARMACEUTICAL PREPARATION MANUFACTURING solicitation, performed in Bethesda, MD, with responses due 2026-05-06. AwardCast estimates what this specific solicitation will close for, before you bid.
What's being bought
The purpose of this acquisition is to purchase 503b compounded Intravenous (IV) Narcotics for patient care. Market research has been conducted with only two responses, from QUVA, the known Compounder and distributor for these IV narcotics. Through trade shows, continuous learning seminars and trade
Comparable recent awards in PHARMACEUTICAL PREPARATION MANUFACTURING
| Winner | Award value | Offers | Date |
|---|---|---|---|
| UNITED THERAPEUTICS CORP | $17K | 1 | 2026-07-02 |
| COVERMYMEDS PHARMACY LLC | $16K | 1 | 2026-07-02 |
| PRIORITY HEALTHCARE DISTRIBUTION INC | $16K | 1 | 2026-07-02 |
| THERACOM, L.L.C. | $38K | 1 | 2026-07-02 |
| SRI INTERNATIONAL | $49.9M | 7 | 2026-07-02 |
Questions
What is solicitation NOI-OD-26-000038?
NOI to Sole Source to QuVa Pharma, Inc., issued by HEALTH AND HUMAN SERVICES, DEPARTMENT OF, under NAICS 325412 (PHARMACEUTICAL PREPARATION MANUFACTURING), performed in Bethesda, MD. Responses are due 2026-05-06.
What do similar contracts close for?
Comparable closed awards in this category ran from $16K to $49.9M, across 5 awards shown above. Those are historical results, not a forecast for this solicitation.
Is NOI-OD-26-000038 set aside?
NONE. Check the notice on SAM.gov for the eligibility language that governs.
Explore the market
Forecast Report — what a specific solicitation will close for: the predicted price range, the competition to expect, and comparable awards already closed. Before you price your bid.
Every forecast is scored against the real award once it becomes public. See the track record.
Closed awards from public federal data, not the forecast. One email, no account.
Or get the forecast for this solicitation — $49, one report.